Radiation Therapy for Prostate Cancer: Types, Side Effects and Cost

Radiation therapy, also called radiotherapy, uses high-energy radiation to damage the DNA of cancer cells. This guide sits beside the Prostate Cancer Treatment in India pathway, the treatment-without-surgery guide, the treatment-options explainer and Robotic Prostatectomy in India.

When the damage is severe enough, cancer cells can no longer continue growing and dividing.

Radiation can be directed at the prostate from outside the body or delivered directly into the prostate.

That creates two major treatment categories:

Radiation comes from a machine outside the body. See EBRT cost in India.

A radioactive source is placed inside or immediately next to the prostate. See brachytherapy cost.

Both approaches can be used to treat prostate cancer, but they are used differently depending on the patient's cancer and anatomy.

International patients comparing radiation oncologists commonly start with Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad.

Yes.

For appropriately selected men with localized prostate cancer, radiation can be used as a definitive treatment with curative intent.

This is an important point for patients who assume radiation is only used when surgery cannot be performed.

Radiation can be a primary treatment option alongside radical prostatectomy for selected localized cancers.

The American Cancer Society states that external beam radiation can be used as the initial treatment for prostate cancer confined to the prostate, while brachytherapy is also an established treatment for selected patients.

Radiation can be used at several points in the prostate cancer journey.

For selected localized prostate cancer, radiation may be used instead of surgery.

Men with higher-risk or locally advanced disease may receive radiation together with androgen deprivation therapy (ADT).

The combination can provide better cancer control than radiation alone in appropriate higher-risk settings.

Some patients may receive radiation after prostatectomy.

This can happen when:

Radiation may be used when prostate cancer returns after previous treatment, depending on where the recurrence occurs and what treatment the patient received initially.

Radiation can be used to relieve symptoms from metastatic cancer.

For example, radiation may be given to a painful bone metastasis.

In selected patients, radiation can also be used to treat specific sites of disease even when systemic treatment remains the main treatment.

Radiation therapy is not one single treatment.

Modern prostate cancer radiation includes several techniques.

The most important are:

External beam radiation therapy (EBRT) delivers radiation from a machine outside the patient's body.

The machine is usually a linear accelerator, commonly called a LINAC.

The patient lies on a treatment table while the machine directs radiation toward the prostate.

Modern treatment planning is highly precise.

The goal is to deliver an effective dose to the cancer while reducing unnecessary radiation exposure to nearby organs.

The organs of particular concern include:

Before treatment begins, the radiation oncology team creates a treatment plan.

Imaging is used to identify:

The radiation oncologist then develops a treatment plan that determines:

The treatment is then delivered according to that plan.

Intensity-modulated radiation therapy (IMRT) is one of the most widely used modern forms of external beam radiation.

With IMRT, radiation intensity can be varied across different portions of the treatment field.

This allows the radiation team to shape the dose around the prostate.

The objective is to:

Deliver sufficient radiation to the target while reducing radiation to nearby healthy tissues.

IMRT is particularly useful because the prostate sits close to the bladder and rectum.

The American Cancer Society describes IMRT as a form of external radiation in which the radiation intensity can be adjusted to better shape the treatment dose.

GAF planning range for IMRT in India is $6,500–$14,500, typically over about 4–7 weeks of fractions.

Image-guided radiation therapy (IGRT) uses imaging during the treatment process to improve positioning.

This is important because the prostate is not completely fixed in place.

Its position can change slightly depending on:

IGRT helps the treatment team verify the patient's position before or during treatment.

This can improve targeting accuracy.

GAF planning range for IGRT is $7,200–$16,000.

Volumetric modulated arc therapy (VMAT) is an advanced form of external beam radiation.

Instead of delivering radiation from a limited number of fixed angles, the machine can rotate around the patient while continuously adjusting:

This allows treatment to be highly conformal.

One practical advantage is that individual treatment sessions can be relatively short.

Stereotactic body radiation therapy (SBRT) delivers a highly focused radiation dose in a small number of treatment sessions.

Because each session delivers a higher dose, the overall treatment course can be much shorter than conventional radiation.

For appropriately selected prostate cancer patients, SBRT may be completed in approximately five treatment sessions.

The American Cancer Society describes SBRT as a form of external radiation that can deliver the complete treatment over a much shorter schedule than conventional radiation.

GAF planning range for SBRT is $8,000–$17,500, typically about 1–5 sessions.

SBRT is not automatically suitable for every patient.

The radiation oncologist considers:

SBRT is increasingly used for appropriately selected localized prostate cancer.

It can be particularly attractive for patients who live far from the treatment centre because the number of hospital visits is much lower than with conventional schedules.

Brachytherapy is a form of internal radiation therapy.

Instead of delivering radiation from outside the body, a radioactive source is placed directly inside or close to the prostate.

This allows a high radiation dose to be delivered to the prostate while limiting exposure to surrounding tissues.

There are two major forms.

LDR brachytherapy uses small radioactive seeds.

The seeds are inserted into the prostate using needles under imaging guidance.

They remain inside the prostate and release radiation gradually over time.

LDR brachytherapy can be used as:

The American Cancer Society notes that seed implantation is an established form of prostate brachytherapy and is generally used for selected localized cancers.

HDR brachytherapy uses a radioactive source that is temporarily placed inside the prostate.

The radioactive source is removed after the prescribed dose is delivered.

Unlike LDR brachytherapy, radioactive material is not permanently left inside the body.

HDR brachytherapy may be used:

The treatment schedule depends on the radiation centre and clinical protocol.

GAF planning range for brachytherapy in India is $5,500–$13,000, typically with a 1–7 night stay depending on the technique.

Neither approach is automatically appropriate for every patient.

Treatment selection changes considerably according to risk.

Many patients with very-low-risk disease can be managed with active surveillance.

Radiation is still an option for selected patients who want definitive treatment.

Radiation options may include:

Active surveillance may also remain an option. See treatment without surgery.

Radiation becomes an important definitive treatment.

Depending on the risk subtype, options may include:

Favorable and unfavorable intermediate-risk disease should not be treated as identical categories.

High-risk prostate cancer often requires combination treatment.

A common non-surgical pathway is:

External beam radiation + hormone therapy

Some patients may also be considered for a brachytherapy boost.

The duration and intensity of hormone treatment depend on the risk group and clinical plan.

For cancer extending outside the prostate but without distant metastases, radiation may be combined with systemic treatment.

The treatment field may include:

The exact treatment depends on staging.

When cancer has spread to distant sites, systemic therapy usually forms the foundation of treatment.

Radiation may still be important.

It can be used to:

Radiation can also be used after prostate surgery.

There are two broad situations.

Radiation may be considered based on adverse pathological findings after surgery.

Radiation may be given when PSA becomes detectable or begins to rise after surgery, suggesting possible recurrence.

The timing of salvage radiation is an important clinical decision.

The American Cancer Society notes that radiation may be used after prostatectomy when there is concern that cancer remains or has returned.

Salvage radiation is radiation given after an initial treatment when cancer appears to have returned.

After prostatectomy, PSA is closely monitored.

If PSA begins to rise, doctors may consider salvage radiation before the disease becomes more extensive.

Whether it is appropriate depends on:

The decision should be made by a specialist team.

In prostate cancer, radiation is more commonly used as a definitive treatment instead of surgery or as part of treatment for higher-risk disease.

Routine radiation before radical prostatectomy is not the standard approach for most localized prostate cancers.

The treatment plan should therefore be based on the specific cancer stage and risk group.

Radiation treatment starts with a planning process called simulation.

The patient is positioned in the same way that will be used during treatment.

Imaging is performed to identify the prostate and surrounding organs.

The radiation oncologist then defines:

Where the cancer is located or where cancer cells are likely to exist.

Healthy tissues that should receive as little radiation as reasonably possible.

These may include:

A computer-based treatment plan is then created.

The prostate sits between the bladder and rectum.

Their position can change depending on how full they are.

Radiation centres may therefore provide instructions about:

Following these instructions helps the treatment team reproduce a similar anatomy during each session.

Some radiation centres use small markers called fiducial markers.

These markers are placed in or around the prostate and can be seen on imaging.

They help the radiation team identify the prostate's position more accurately during treatment.

They can be particularly useful when highly precise radiation such as SBRT is being delivered.

Some centres use a temporary hydrogel spacer between the prostate and rectum.

The objective is to increase the physical distance between the prostate and rectal wall.

This can help reduce radiation exposure to the rectum in selected patients.

A spacer is not required for every patient.

The radiation oncologist decides whether it is appropriate.

The number of sessions depends on the treatment technique.

May involve multiple weeks of treatment. EBRT planning ranges often assume about 15–35 sessions.

Can be delivered in a small number of sessions, often around five.

Can involve one implantation procedure.

May involve one or more treatment sessions depending on the protocol.

The exact schedule should be confirmed with the treating radiation oncology team.

The actual radiation delivery can be relatively quick.

However, the entire appointment can take longer because of:

Patients should therefore distinguish between radiation delivery time and total time at the radiation centre.

External beam radiation itself is generally not painful.

The patient lies on the treatment table while the machine delivers radiation.

There is no cutting or incision.

However, side effects can develop during or after the course of treatment.

Brachytherapy is different because it involves an invasive procedure to place the radioactive source.

Anaesthesia or sedation may be used depending on the technique.

Radiation side effects vary between patients.

They depend on:

Side effects are usually divided into short-term effects and long-term effects.

During or shortly after radiation, some patients may experience:

These symptoms can occur because the bladder and urethra receive some radiation exposure.

The American Cancer Society lists urinary frequency, urgency and other urinary symptoms among possible effects of prostate radiation.

Radiation can also affect the rectum.

Possible symptoms include:

Modern radiation techniques are designed to reduce exposure to the rectum.

However, the risk cannot be completely eliminated.

Fatigue is another common concern.

It may develop gradually during treatment.

Some patients continue normal daily activities.

Others feel increasingly tired as treatment progresses.

Fatigue may improve after treatment ends, although recovery time varies.

Radiation can affect sexual function.

Erectile dysfunction may develop gradually rather than immediately.

The risk can increase over time.

Factors include:

Radiation can also affect ejaculation.

Patients should discuss sexual health before treatment rather than waiting until after treatment.

When radiation is combined with ADT, some symptoms commonly attributed to “radiation” may actually come from hormone therapy.

These can include:

This distinction matters when comparing radiation alone with radiation plus hormone therapy.

Some urinary symptoms can persist after treatment.

Possible long-term problems include:

Severe long-term urinary complications are less common with modern treatment but remain possible.

Possible long-term bowel effects include:

Modern image-guided and intensity-modulated techniques aim to reduce these risks.

Yes.

Radiation can affect the blood vessels and nerves involved in erections.

Unlike surgery, the effect may not be immediate.

Some men notice a gradual decline in erectile function over months or years.

Hormone therapy can further reduce sexual function while it is being administered.

Both surgery and radiation can affect urinary and sexual function, but the pattern is different.

The right comparison is therefore not simply “which has fewer side effects.”

It is:

Which side-effect profile is more acceptable for the individual patient?

Radiation can very rarely contribute to the development of a second cancer years after treatment.

The absolute risk is considered low.

The potential long-term benefit of treating prostate cancer must be weighed against the known risks and side effects of treatment.

This should be discussed with the radiation oncologist.

Patients with significant urinary obstruction may require additional assessment before radiation.

Symptoms such as:

should be discussed before treatment begins.

Radiation can temporarily worsen urinary symptoms.

An enlarged prostate does not automatically prevent radiation treatment.

However, prostate size and urinary symptoms can influence:

The radiation oncologist evaluates prostate anatomy before deciding on the technique.

India has major cancer centres offering modern radiation technologies.

Depending on the hospital, available techniques may include:

Availability differs by hospital.

International patients should confirm the exact technology and treatment schedule before travelling. Compare radiation hospitals in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad.

There is no single fixed price for radiation therapy.

Published estimates vary according to:

Vaidam currently publishes an indicative estimate of approximately ₹2.56 lakh–₹3.33 lakh for prostate cancer radiation therapy in India.

This should be treated as a reference range rather than a guaranteed hospital price.

GAF Healthcare planning ranges, which international patients usually compare in USD, include EBRT $1,000–$6,000+, IMRT $6,500–$14,500, IGRT $7,200–$16,000, SBRT $8,000–$17,500, brachytherapy $5,500–$13,000 and hormone therapy $1,000–$4,500. These are planning ranges, not quotations.

City pages use the same national ranges unless a hospital issues a verified quotation: Delhi NCR EBRT, Mumbai IMRT, Bengaluru SBRT, Chennai brachytherapy and Hyderabad IGRT.

These are cost patterns rather than fixed prices.

A hospital may structure its package differently.

Before accepting a quotation, ask whether it includes:

Some of these may be billed separately.

Several factors can increase the total cost.

SBRT and sophisticated image-guided techniques may have higher planning and equipment costs.

A longer treatment course creates more treatment visits.

Brachytherapy involves a procedure, specialised planning and radioactive sources.

Hormone treatment can substantially increase the overall cost when it continues for months.

MRI, PSMA PET/CT and other tests may be required.

High-risk cancers may require combination treatment.

Coverage depends on the patient's insurance policy.

Patients should check:

International patients should verify their insurance coverage before travelling.

International patients should ideally complete as much of the diagnostic review as possible before arriving in India.

Send:

The radiation oncology team can then determine:

This depends heavily on the technique.

May require several weeks of treatment.

May require only a small number of treatment visits.

May involve a procedure followed by recovery.

May involve one or more treatment sessions.

Patients should therefore choose accommodation based on the entire radiation schedule, not simply the first hospital appointment.

Both can be definitive treatments for appropriately selected localized prostate cancer.

Neither option is universally appropriate. See Robotic Prostatectomy in India for the surgical pathway.

These are fundamentally different approaches.

The cancer is monitored without immediate definitive treatment.

The cancer is actively treated.

Active surveillance may be appropriate for selected low-risk cancers.

Radiation may be appropriate when the patient wants definitive treatment or when the cancer's risk profile requires active treatment.

Yes.

This is common in higher-risk prostate cancer.

Hormone therapy reduces androgen stimulation of prostate cancer cells.

Radiation then treats the prostate and relevant treatment area.

The combination can improve cancer control in appropriate high-risk and locally advanced disease.

The duration of hormone therapy varies according to the clinical setting. Medical oncologists plan ADT when it is added.

Hormone therapy can:

It can also produce significant side effects.

The decision to add ADT should therefore be based on the patient's risk group rather than simply because radiation is being used.

Radiation does not remove the prostate.

The prostate remains in place.

PSA therefore does not necessarily become immediately undetectable.

Instead, PSA usually falls gradually.

It can take time to reach its lowest level.

A temporary rise in PSA can also occur in some patients after radiation, sometimes called a PSA bounce.

The treating doctor interprets PSA based on the timing and overall trend.

A PSA bounce is a temporary increase in PSA followed by another decline.

It can occur after radiation, particularly in younger patients and after certain brachytherapy approaches.

A PSA increase does not automatically mean that cancer has returned.

The doctor considers:

PSA monitoring is the primary follow-up tool.

Doctors may order additional imaging when:

PSMA PET/CT can be useful in selected patients with biochemical recurrence. Related: PSMA PET/CT for Prostate Cancer.

Treatment depends on where the recurrence is located.

Options may include:

Salvage surgery after radiation is more complex and has a different risk profile from primary prostatectomy.

Preparation depends on the treatment technique.

For external beam radiation, the centre may instruct the patient to:

For brachytherapy, additional pre-operative instructions may be required.

Always follow the specific protocol given by the radiation oncology team.

Before starting treatment, ask:

Fact: Radiation is an established definitive treatment for selected localized prostate cancers.

Fact: Treatment schedules vary. SBRT can deliver treatment in a small number of sessions for appropriately selected patients.

Fact: External beam radiation itself is generally painless. Side effects can develop during or after treatment.

Fact: Modern planning and image-guided techniques aim to reduce radiation exposure to the rectum, although bowel side effects remain possible.

Fact: Radiation damages cancer cells over time. The prostate remains in place.

Fact: Unlike prostatectomy, radiation does not remove the prostate. PSA can decline gradually and may temporarily fluctuate.

Fact: SBRT is an option for appropriately selected patients. Cancer characteristics, prostate anatomy and urinary function all matter.

External beam radiation therapy is a major radiation approach. Modern forms include IMRT, IGRT and VMAT.

IMRT is an external radiation technique that changes the intensity of radiation across the treatment field to shape the dose more precisely around the prostate.

IGRT uses imaging to verify the patient's position and improve targeting during radiation treatment.

VMAT delivers radiation while the treatment machine rotates around the patient and continuously changes the beam characteristics.

SBRT delivers a high dose of radiation in a small number of treatment sessions. It can be used for appropriately selected prostate cancer patients.

Brachytherapy places radioactive material inside or near the prostate to deliver radiation directly to the treatment area.

Neither is universally better. The appropriate technique depends on the cancer, prostate anatomy, urinary function and the patient's circumstances.

Yes. Radiation can be used as a definitive treatment with curative intent for appropriately selected localized prostate cancer.

Yes. Radiation combined with hormone therapy is an important treatment approach for selected high-risk and locally advanced disease.

Radiation can treat selected sites of metastatic disease, particularly for symptom control. Systemic treatment generally plays the central role in metastatic prostate cancer.

It can. Frequency, urgency, burning and changes in urinary flow may occur during or after treatment.

It can. Loose stools, urgency, rectal irritation and bleeding are possible side effects.

Yes. Erectile function can decline after radiation, sometimes gradually over time.

Radiation to the prostate can affect fertility and ejaculation. Men who may want biological children should discuss fertility preservation before treatment.

Many patients can continue some normal activities during treatment, but fatigue and urinary or bowel symptoms can affect daily life.

It depends on the treatment schedule. Long-distance travel during a multi-week treatment course can be difficult, so patients should plan accommodation near the treatment centre.

Published estimates vary. One current estimate places prostate cancer radiation therapy at approximately ₹2.56 lakh–₹3.33 lakh. GAF Healthcare planning ranges include EBRT $1,000–$6,000+, IMRT $6,500–$14,500, IGRT $7,200–$16,000, SBRT $8,000–$17,500 and brachytherapy $5,500–$13,000. Actual hospital prices depend on the treatment technique, number of sessions, technology and whether additional treatment is required.

The cost per session can be higher because of advanced planning and technology, but the overall cost depends on the number of sessions and hospital package.

Not necessarily. Some hospitals quote radiation separately from hormone therapy. Patients should specifically ask whether ADT is included.

It depends on the technique. Conventional schedules can take several weeks, while SBRT may be completed in approximately five sessions.

No. The prostate remains in place.

Not necessarily. PSA usually falls gradually because the prostate remains in the body.

Yes. Recurrence can occur after definitive radiation, which is why long-term PSA monitoring is required.

Salvage prostatectomy is possible for selected patients but is more complex and carries higher complication risks than primary surgery.

Radiation therapy is one of the most important non-surgical treatments for prostate cancer.

Modern radiation is not a single technique.

It includes:

For localized prostate cancer, radiation can be used as a definitive treatment with curative intent.

For higher-risk disease, it is often combined with hormone therapy.

For metastatic disease, radiation may be used to control specific symptoms or sites of cancer while systemic treatment remains central.

The choice of radiation technique depends on cancer stage, Grade Group, PSA, risk group, prostate size, urinary function, imaging, previous treatment and overall health.

Modern radiation techniques are designed to improve precision and reduce unnecessary exposure to nearby organs, but side effects remain possible.

For international patients travelling to India, the treatment budget should include not only radiation delivery but also consultation, treatment planning, imaging, hormone therapy when required, accommodation and the duration of the treatment schedule.

For patients researching prostate cancer treatment in India, these articles sit together as a cluster:

The main internal link should point back to the flagship Prostate Cancer Treatment in India page, while this article remains focused on radiation-specific search intent.

GAF Healthcare coordinates international patients who want radiation therapy for prostate cancer in India. Share PSA reports, biopsy and Grade Group, MRI or PSMA PET, and previous treatment records. A coordinator can arrange review with a radiation oncologist, an itemized estimate and travel planning around the session schedule. The treating radiation oncology team makes the final recommendation.

This article is for general educational purposes and does not replace consultation with a qualified radiation oncologist, urologist or medical oncologist.

The appropriate radiation technique, dose, treatment schedule and combination with hormone therapy depend on the individual's cancer stage, Grade Group, PSA, imaging, urinary function and overall health.

Radiation side effects and treatment outcomes vary between patients. Published treatment costs are indicative and can change. Patients should obtain a current treatment plan and written quotation from the treating hospital before making medical or travel arrangements.

1. American Cancer Society — Radiation Therapy for Prostate Cancer — external beam radiation, IMRT, SBRT, brachytherapy, side effects and radiation after surgery.

2. National Cancer Institute — Prostate Cancer Treatment — radiation, hormone therapy and treatment by stage.

3. European Association of Urology — Prostate Cancer Guidelines — radiation, risk classification and current treatment strategies.

4. American Cancer Society — Treatment by Stage — when radiation is used for low-, intermediate-, high-risk and advanced disease.

5. Vaidam Health — Prostate Cancer Treatment Cost in India — indicative India-specific cost reference for radiation therapy.

Last reviewed against the cited sources: September 2026.